Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste receptor type 2 member 7 is a G protein-coupled receptor encoded by the *TAS2R7* gene. It is specifically expressed in taste receptor cells of the tongue and palate epithelia, where it mediates the detection and signal transduction of bitter tastants. TAS2R7 belongs to the large family of bitter taste receptors (TAS2Rs), which are characterized by diverse agonist profiles ranging from narrowly to broadly tuned sensitivity to bitter chemicals. The canonical pathway involves activation through gustducin and downstream effectors like PLCβ2 and TRPM5, resulting in taste signal transmission to the brain. In addition to its classical role in oral bitter sensing, TAS2R7 and other members of the TAS2R family are expressed in extraoral tissues, potentially contributing to non-gustatory functions such as immune and metabolic regulation. No specific clinical drugs or disease associations are established for TAS2R7, though its ability to bind multiple bitter compounds makes it relevant for flavor and nutrition studies[1][2][3][4].
The receptor binds bitter molecules (agonists), activates G protein gustducin, triggering downstream signal transduction including PLCβ2 activation, production of IP₃, calcium release, TRPM5 channel activation, and action potential generation in taste receptor cells. Antagonists: molecules that block TAS2R7-mediated bitter sensing
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 member 7 (TAS2R7).